Skip to main content
Fig. 1 | Orphanet Journal of Rare Diseases

Fig. 1

From: Safety and effectiveness of taliglucerase alfa in patients with Gaucher disease: an interim analysis of real-world data from a multinational drug registry (TALIAS)

Fig. 1

Exposure-adjusted incidence rate by system organ class and treatment group. *Hypersensitivity reactions include chest pain, urticaria, rash, localized edema, eye edema, eye pruritus, eye swelling, lip edema, throat irritation, and throat tightness. These patients were also counted in the associated system organ classes. ERT enzyme replacement therapy; SOC system organ class; SRT substrate reduction therapy; Trt treatment

Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172